(Q46089144)

19 December 2017

title

Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults (English)

1 reference

19 December 2017

Christina N Lessov-Schlaggar

author

2

object named as

Christina N Lessov-Schlaggar

1 reference

19 December 2017

1

Gary E Swan

1 reference

19 December 2017

Dorit Carmelli

3

object named as

Dorit Carmelli

1 reference

19 December 2017

author name string

Gerard D Schellenberg

4

1 reference

19 December 2017

Asenath La Rue

5

1 reference

19 December 2017

publication date

1 December 2005

1 reference

19 December 2017

Journal of Geriatric Psychiatry and Neurology

published in

1 reference

19 December 2017

volume

18

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

196-201

1 reference

19 December 2017

Apolipoprotein E and cognitive performance: a meta-analysis.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Apolipoprotein e4 allele and cognitive decline in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Apolipoprotein E, cardiovascular disease and cognitive function in aging women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

MMSE items predict cognitive decline in persons with genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Memory decline in healthy older people: implications for identifying mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Guidelines of the National Heart, Lung, and Blood Institute Working Group on Blood Drawing, Processing, and Storage for Genetic Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Protection against Alzheimer's disease with apoE epsilon 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

Cognitive decline in women in relation to non-protein-bound oestradiol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281864

21 January 2018

Identifiers

DOI

10.1177/0891988705281864

1 reference

19 December 2017

1 reference

19 December 2017